Status:
COMPLETED
Impact of Underlying Renal Disease and Immunosuppressive Regimen on Ovarian Reserve in Renal Patients
Lead Sponsor:
Wroclaw Medical University
Conditions:
Anti-Mullerian Hormone Deficiency
Immunosuppression
Eligibility:
FEMALE
18-44 years
Brief Summary
Aging, renal pathology (eg SLE, ADPKD), X-ray exposition and pharmacological treatments, especially previous strong immunosuppression, may negatively influence the ovarian reserve in childbearing age ...
Eligibility Criteria
Inclusion
- Conscious written approval
- Autoimmunological disorder with kidneys affection/ kidney transplant recipient- Regular menstrual cycles
- Age above 18 years old
Exclusion
- Irregular menstrual cycles
- Menopause
- PCOS
- Chemiotherapy or radiotherapy in the past
- Surgical interventions within ovaries
- Hypogonadotropic hypogonadism
- Folliculoma
- Age under 18 years old
Key Trial Info
Start Date :
June 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2020
Estimated Enrollment :
153 Patients enrolled
Trial Details
Trial ID
NCT04762615
Start Date
June 1 2018
End Date
December 1 2020
Last Update
February 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nephrology and Transplantation Clinic University Hospital in Wrocław
Wroclaw, Poland, 50-556